SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-104488
Filing Date
2020-09-11
Accepted
2020-09-11 17:19:49
Documents
1
Period of Report
2020-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2030658d1_4.html 4  
1 OWNERSHIP DOCUMENT tm2030658d1_4.xml 4 4100
  Complete submission text file 0001104659-20-104488.txt   5616
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
PRENDERGAST FRANKLYN G (Reporting) CIK: 0001233256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 201171767